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Background: Enterococci, ubiquitous colonizers of humans and other animals, play an increasingly important role
in health-care associated infections (HAIs). It is believed that the recent evolution of two clinically relevant species,
Enterococcus faecalis and Enterococcus faecium occurred in a big part in a hospital environment, leading to
formation of high-risk enterococcal clonal complexes (HiRECCs), which combine multidrug resistance with increased
pathogenicity and epidemicity. The aim of this study was to establish the species composition in wastewater, its
marine recipient as well as a river estuary and to investigate the antimicrobial susceptibility of collected isolates.
Molecular methods were additionally applied to test the presence of HiRRECC-related E. faecium.
Results: Two wastewater treatment plants (WWTPs), their marine outfalls and Vistula river that influence
significantly the quality of waters in Gulf of Gdansk were sampled to investigate the presence of Enterococcus spp.
Four-hundred-twenty-eight isolates were obtained, including E. faecium (244 isolates, 57.0%), E. hirae (113 isolates,
26.4%) and E. faecalis (63 isolates, 14.7%); other species (E. gallinarum/casseliflavus, E. durans and E. avium) accounted
for 1.9%. Antimicrobial susceptibility testing revealed the presence of isolates resistant to erythromycin, tetracycline,
amipicillin, fluoroquinolones and aminoglycosides (high-level resistance), especially among E. faecium, where such
isolates were usually characterized by multilocus sequence types associated with nosocomial lineages 17, 18 and
78 of this species representing HiRECC, formerly called CC17. These isolates not only carried several resistance
determinants but were also enriched in genes encoding pathogenicity factors (Esp, pili) and genes associated with
mobile genetic elements (MGE), a feature also typical for nosocomial HiRECC.
Conclusions: Our data show that WWTPs constitute an important source of enterococcal strains carrying
antimicrobial resistance determinants, often associated with the presence of MGE, for the recipient water
environment, thus increasing a pool of such genes for other organisms. The presence of HiRECCs in wastewaters
and marine/river environment may indicate that adaptations gained in hospitals may be also beneficial for survival
of such clones in other settings. There is an obvious need to monitor the release and spread of such strains in
order to elucidate better ways to curb their dissemination.
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Enterococci are commensal bacteria of intestinal tract
of mammals and birds, but these bacteria can also be
found in the gut of reptiles and insects, and in different
environmental compartments like soil and plants, in
food (both as starters and contamination) as well as in
aquatic ecosystems, both distributed with treated waste-
water and lacking such anthropogenic impact [1]. In the
human intestine, the Enterococcus faecalis and Entero-
coccus faecium are most abundant, and these two
species are also most commonly isolated from human
enterococcal infections, however, other species, such as
Enterococcus avium, Enterococcus casseliflavus, Entero-
coccus durans, Enterococcus gallinarum, and Entero-
coccus raffinosus have also been detected [2,3]. Recently
E. faecalis and E. faecium play more and more import-
ant role in hospital-acquired infections (HAIs), such as
bacteremia, endocarditis, infections of urinary tract and
post-surgery wounds [4], and nowadays represent a sec-
ond etiologic agent of hospital bloodstream infections
in Europe [5]. In the recent years, the relative propor-
tion of E. faecium to E. faecalis is increasing in the US
and Europe [6-8], which is likely due to the spread of a
particular hospital-adapted polyclonal high-risk entero-
coccal complex (HiRECC) of E. faecium, initially described
as clonal complex 17, CC17 [8]. This nosocomial subpop-
ulation consists of three main lineages, named from the
central sequence type (ST), defined by multilocus se-
quence typing (MLST), as lineages 17, 18 and 78 [9]. The
acquisition of resistance to antimicrobials of several clas-
ses constitutes an important feature of hospital-associated
E. faecium, what not only renders them resilient to ther-
apy but also creates a reservoir of antimicrobial resistance
genes, often associated with mobile genetic elements
(MGE), such as conjugative transposons and plasmids
[10]. The most important from the clinical point of view
examples of acquired resistance among enterococci in-
clude resistance to (amino)penicillins, fluoroquinolones,
glycopeptides (vancomycin-resistant enterococci, VRE)
and high-level resistance to aminoglycosides (HLAR)
[3]. Resistance to ampicillin, associated with the changes
in penicillin binding protein 5 (PBP5) and resistance to
quinolones, determined by point mutations in genes en-
coding bacterial gyrase and topoisomerase IV are char-
acteristic phenotypic features of nosocomial E. faecium
[11,12]. Such strains also commonly carry resistance
genes to other classes of antimicrobials, such as tetracy-
clines {tet(M), tet(L), tet(S) and tet(O)}, macrolides {erm
(B)} and aminoglycosides [13]. The HLAR phenotype is
usually determined by the aac(6′)-Ie-aph(2″) gene, en-
coding a so-called bi-functional enzyme responsible for
resistance to all aminoglycosides, except for streptomycin;
high-level resistance to this compound is typically speci-
fied by ant(6′)-Ia [3]. Hospital-associated E. faecium isalso enriched in several virulence factors, such as en-
terococcal surface protein (Esp) and MSCRAMM pro-
teins [14-16].
Several studies have addressed the spread of HiRECCs,
especially VRE, within as well as among health-care facil-
ities [17]. Much less is known, however, about the release
of drug-resistant enterococci and HiRECCs into the envir-
onment, and their subsequent survival. Since it is sus-
pected that human-associated bacteria can be regarded as
vectors of gene transmission into environmental popula-
tions [18] and positive selection of bacteria resistant to
antimicrobial agents was observed in wastewater processes
[19,20], the potential role of effluents from wastewater
treatment plant (WWTP) in dissemination of clinically
relevant bacteria and genes needs evaluation. It is particu-
larly important in ecosystems subjected to strong an-
thropogenic impact, such as the Gulf of Gdansk and its
shallow western part, the Puck Bay. Significant pollution
load is discharged to this coastal area through the numer-
ous local rivers and marine outfalls. Due to limited water
exchange in the Gulf of Gdansk, safe wastewater disposal
is essential to prevent the environmental degradation and
to preserve the public health. Epidemiological studies
reported a direct relationship between the risk of gastro-
enteritis among swimmers and density of enterococci in
surface waters [21]. Additionally, resistant and multiresis-
tant enterococci were detected in effluent of WWTPs
[18,20,22], suggesting their survival capacity in treatment
processes. However, no microbiological standards have
been set on WWTP effluents in the majority of European
countries and it is required instead to monitor the quality
of recreational water [23]. The US Environmental Protec-
tion Agency [21] as well as the European Union legislation
[23] recommended detection of fecal enterococci, together
with Escherichia coli as indicators of fecal contamination
of bathing water.
Aim of the current study was to investigate the pres-
ence and species composition of enterococci in treated
wastewater, river estuary water and their recipient,
highly anthropogenically impacted Gulf of Gdansk. For
this purpose, enterococci were isolated from wastewater
of two local WWTPs, Gdansk-Wschod (influent - W-INF,
effluent - W-EFF and bioreactor - W-BR) and Gdynia-
Debogorze (effluent - D-EFF) as well as from their marine
outfalls (W-MOut and D-MOut, respectively). Add-
itionally, the Vistula River mouth was sampled, due to
ecological importance of this river flows for the Gulf
of Gdansk area (Figure 1). Identification and further
characterization of drug-resistant enterococci, especially
the most prevalent E. faecium, including its resistance,
virulence and MGE genes was in the special focus of the
study, due to the problem posed by such clones for safe,








Figure 1 Sampling sites location: WWTP Gdansk-Wschod – influent (W-INF), bioreactor (W-BR), effluent (W-EFF) and marine outfall
(W-MOut); WWTP Gdynia-Debogorze effluent (D-EFF) and marine outfall (D-MOut); Vistula River mouth (VR). Both WWTPs treat mainly
municipal wastewater; industrial and not disinfected hospital wastewater consist approximately 10% and 0.2% of daily inflow, respectively. The
WWTP Gdansk-Wschod works in a modified University of Cape Town system; Qav. = 96 000 m3/d; serves 570 000 people; in operation since 2001.
The WWTP Gdynia-Debogorze works in Bardenpho system, including the Barnard modification; Qav. = 55 000 m3/d; serves 350 000 people; in
operation since 2011. The Vistula River is the second biggest river (1 048 km long) in the catchment’s area of the Baltic Sea; the average flow at
the mouth to the Baltic Sea ca. 1050 m3·s−1.
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Species composition and antimicrobial susceptibility of
enterococcal isolates
In this study, the number of enterococci in WWTP efflu-
ents (W-EFF and D-EFF) remained high for both WWTP,
yielding up to 6.1x105 CFU per 100 mL (Table 1), although
the WWTP Gdansk-Wschod showed over 99% efficiency
in the removal of enterococci. In marine outfalls of the two
WWTPs (W-MOut, D-MOut) as well as at the VistulaTable 1 Presence (CFU 100 mL−1) of enterococci, number (%)
composition at particular sites
Gdansk-W
W-INF W-BR
Presence CFU 100 mL−1 (0.7–23) × 107 na (
Number (%) of recovered isolates 33 (7.7) 55 (12.8)
Species composition:
number (%)
E. faecium 19 (57.6) 36 (65.5)
E. faecalis 5 (15.2) 8 (14.5)
E. hirae 8 (24.2) 11 (20.0)
E.casseliflavus/gallinarum 1 (3.0) nd
E. durans nd nd
E. avium nd nd
na – not applicable, nd – not detected.
Abbreviations of sampling points’ locations and their description provided in FigureRiver mouth, enterococci were detected at low densities,
i.e. below 100 CFU per 100 mL. Altogether, 428 isolates
were collected, including 243 isolates from wastewater, 116
isolates from marine outfalls, and 69 from Vistula River
mouth (Table 1). These 428 isolates were mainly identified
as E. faecium (altogether 244 isolates, 57%), Enterococcus
hirae (113 isolates, 26.4%) and E. faecalis (63 isolates,
14.7%), with an occasional occurrence of E. gallinarum/
casseliflavus, E. durans and E. avium (4, 3, and 1 isolates,of enterococcal isolates recovered and species
WWTP Vistula
river Totalschod Gdynia-Debogorze
W-EFF W-MOut D-EFF D-MOut VR
0.1–6.1) × 105 3 – 60 (0.8–3.1) × 105 2 – 80 1 – 30 -
82 (19.2) 45 (10.5) 73 (17.1) 71 (16.6) 69 (16.1) 428 (100)
53 (64.6) 29 (64.4) 41 (56.2) 40 (56.3) 26 (37.7) 244 (57)
19 (23.2) 4 (8.9) 19 (26.0) 3 (4.3) 5 (7.2) 63 (14.7)
7 (8.5) 11 (24.4) 12 (16.4) 27 (38.0) 37 (53.6) 113 (26.4)
2 (2.5) nd 1 (1.4) nd nd 4 (1.0)
1 (1.2) 1 (2.3) nd 1 (1.4) nd 3 (0.7)
nd nd nd nd 1 (1.5) 1 (0.2)
1.
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in all sampled sites was E. faecium (56.2% – 65.5%), with
the exception of Vistula River mouth where E. hirae was
predominant (53.6% of isolates), followed by E. faecalis
(37.7%).
In the next step, antimicrobial susceptibility was tested
for E. faecium and E. faecalis isolates (Table 2). It should
be noted that at some points a low number of E. faecalis
isolates was recovered (fewer than 10 isolates) and thus,
certain resistance rates obtained for E. feacalis should be
treated with caution. Resistance to erythromycin was de-
tected with the highest prevalence among both species,
however, rates of resistance to this compound varied
over a broad range. Erythromycin-resistant E. faecium
comprised 36.8% of isolates in raw wastewater (W-INF),
45.3% in treated wastewater (W-EFF) and 58.6% in
marine outflow (W-MOut) of WWTP Gdansk-Wschod.
Similar tendency was seen for E. faecalis isolates where
resistance rates in the sampling points listed above were
equal to 20.0%, 68.4% and 100%, respectively. For WWTP
Gdynia-Debogorze effluent (D-EFF) and marine outflow
(D-MOut), erythromycin resistance rates for E. faecium
varied between 68.2% and 55.0%, respectively, while for E.
faecalis were equal 68.4% and 66.7%, respectively. In the
case of fluoroquinolones, resistance to ciprofloxacin amongTable 2 Antimicrobial resistance of E. faecium and E. faecalis
Num
Resistant to a single antim
GM ST AM CIP LVX
E. faecium
W= INF (n = 19) 1 (5.3) 3 (15.8) 1 (5.3) 6 (31.6) 1 (5.3
W-BR (n = 36) 1 (2.8) 2 (5.6) 1 (2.8) 12 (33.2) 3 (8.3
W-EFF (n = 53) 3 (5.7) 2 (3.8) 4 (7.5) 23 (43.4) 10 (18
W-MOut (n = 29) 0 6 (20.7) 6 (20.7) 13 (44.8) 4 (13.8
D-EFF (n = 41) 1 (2.4) 6 (14.6) 5 (12.2) 13 (31.7) 2 (4.9
D-MOut (n = 40) 1 (2.5) 2 (5) 2 (5) 14 (35.0) 3 (7.5
VR (n = 26) 0 1 (3.8) 0 8 (30.8) 1 (3.8
All (n = 244) 7 (2.9) 22 (9.0) 19 (7.8) 90 (36.9) 24 (9.8
E. faecalis
W-INF (n = 5) 0 1 (20.0) 0 1 (20.0) 0
W-BR (n = 8) 2 (25.0) 2 (25.0) 1 (12.5) 2 (25.0) 2 (25.0
W-EFF (n = 19) 0 1 (5.3) 1 (5.3) 3 (15.8) 3 (15.8
W-MOut (n = 4) 0 0 0 0 0
D-EFF (n = 19) 2 (10.5) 5 (26.3) 0 1 (5.3) 0
D-MOut (n = 3) 1 (33.3) 1 (33.3) 0 0 0
VR (n = 5) 0 0 0 2 (40.0) 0
All (n = 63) 5 (7.9) 10 (15.9) 2 (3.2) 9 (14.3) 5 (7.9
GM, gentamicin; ST, streptomycin; AM, ampicillin; CIP, ciprofloxacin; LVX, levofloxaci
all tested antimicrobial agents; MDR, multiple drug resistance; na, not applicable.
Abbreviations of sampling points’ locations and their description provided in FigureE. faecium varied between 30.8% in Vistula River mouth to
44.8% in W-MOut, while resistance to levofloxacin did not
exceed 20%. Among E. faecalis resistance to ciprofloxacin
and levofloxacin was, in general lower then reported for E.
faecium in the corresponding sampling points (up to
25.0%), except Vistula River mouth. The high-level strepto-
mycin resistance (HLSR) was prevalent and reached 20.7%
for E. faecium isolates from marine outflow of WWTP
Gdansk-Wschod (W-MOut). Also for E. faecalis, HLSR
phenotype was detected among up to 16% of all tested iso-
lates. Resistance to glycopeptides, linezolid and daptomycin
was not detected among all tested enterococci.
Clonal structure of E. faecium isolates, and distribution of
virulence, resistance and MGE genes
Sixty-nine isolates of E. faecium (28.3% of all isolates of
this species) were further subjected to MLST and ana-
lysis of the presence of resistance, virulence and MGE
genes. These isolates presented various phenotypes of re-
sistance to antimicrobial compounds, as described below,
and were obtained mostly from effluents and marine out-
falls of both WWTPs (Table 3). MLST discerned 54 differ-
ent STs (Figure 2), including 23 new ones (STs 632–654).
The comparative eBURST analysis against the whole
MLST E. faecium database (as of the 5th April 2013)ber (%) of isolates
icrobial agent Sensitive MDR
phenotypeTE SYN E S
n = 244
) 5 (26.3) 6 (31.6) 7 (36.8) 6 (31.6) 4 (21.1)
) 7 (19.4) 19 (52.8) 16 (44.4) 10 (27.8) 8 (22.2)
.9) 10 (18.9) 18 (34.0) 24 (45.3) 12 (22.6) 14 (26.4)
) 8 (27.6) 14 (48.3) 17 (58.6) 5 (17.4) 9 (31.0)
) 10 (24.4) 12 (29.2) 28 (68.2) 4 (9.8) 8 (19.5)
) 2 (5.0) 21 (52.5) 22 (55.0) 7 (17.5) 3 (7.5)
) 2 (7.7) 15 (57.7) 11 (42.4) 3 (11.5) 3 (11.5)
) 44 (18.0) 105 (43.0) 125 (51.2) 49 (20.1) 47 (19.3)
n = 63
1 (20.0) na 1 (20.0) 4 (80.0) 0
) 2 (25.0) na 7 (87.5) 1 (12.5) 2 (25.0)
) 4 (21.1) na 13 (68.4) 0 3 (15.8)
0 na 4 (100) 0 0
9 (47.4) na 13 (68.4) 4 (21.1) 5 (26.3)
2 (66.7) na 2 (66.7) 0 1 (33.3)
0 na 1 (20.0) 2 (40.0) 0
) 18 (28.6) na 41 (65.1) 11 (17.5) 11 (17.5)
n; TE, tetracycline; SYN, quinupristin-dalfopristin; E, erythromycin; S, sensitive to
1.
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Table 3 Distribution of virulence genes and resistance determinants among lineages, CCs and STs of E. faecium (Continued)
635 D-EFF 1 1 1 1
636 W-EFF 1 wt R61G 1
637 W-EFF 1 1 1 wt R61G 1 1
638 W-EFF 1 wt R61G
S80I
1
642 W-EFF 1 1 1 1 1
645 D-EFF 1 1 1 1 1
646 W-EFF 1 1 1 1 1
649 W-BR 1 1 1 pbp5-
32
wt R61G 1
650 (3) D-EFF 3 3 pbp5-
27
2 2 2 1 1 3
CC 9
8 D-EFF 1 1 1 1 1 1 1 1 1 1 1
640 W-EFF 1 1 1 1 1
CC 22
21 W-EFF 1 1 1 1 1 1 1 1
22 W-EFF 1 1 1 1 1 1
25 W-EFF 1 1 pbp5-
32
wt R61G 1 1 1
32 (3) W-EFF 3 3 1 wt R61G 2 1
92 W-EFF 1 1 1 1 1
441 W-EFF 1 1 1 1 1 1 1 1
533 W-EFF 1 1 1
633 W-EFF 1 1 1 1 1
644 D-EFF 1 1 1 1 1
CC27
652 W-EFF 1 1 1 1
CC46
47 VR 1 1 1 1
69 D-EFF 1 1 1 1 1 1
CC94
94 W-MOut 1 1 1 1
361 (4) D-EFF,
D-MOut
3 4 4 4 pbp5-
29





















Table 3 Distribution of virulence genes and resistance determinants among lineages, CCs and STs of E. faecium (Continued)
CC296
296 W-EFF 1 1
CC639
639 W-EFF 1 1 1 1 1
CC648
634 W-EFF 1 1 1 1 1
648 W-EFF 1 1 1 1 1
Doubletons
632 W-MOut 1 1 1
Singletons
264 W-INF 1 1 1 1 1 1 1
641 D-EFF 1 1 1 1
643 W-EFF 1 1 1 1 1 1
647 W-MOut 1 1 1 1 1
651 D-EFF 1 1 1 1 1 1
654 VR 1 1 1 1 1 1
All (69) 8 57 49 29 46 6 17 20 17 1 9 4 39 27 14 7 55 2 12 10 5
CC, clonal complex; ST, sequence type; MT, MLVA-type; nd, not determined due to lack of amplification of the pbp5 gene; wt, wild-type; STs associated with MDR phenotype in bold.





















Figure 2 MLST-based similarity tree of E. faecium isolates, constructed using the START software and the UPGMA clustering algorithm.
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http://www.biomedcentral.com/1471-2180/14/66grouped the 38 STs, specific for 50 isolates into the major
‘super-complex 17’, characteristic for this species (data not
shown). Further detailed analysis of the localization of
particular STs within this structure revealed that 11 STs
characteristic for 17 isolates belonged to the nosocomial
complex of E. faecium, representing all three major
lineages 17, 18 and 78 of a former CC17, as defined by
Willems et al. [9] (Table 3). Seventeen STs (20 isolates),
nine STs (11 isolates) and two STs with single isolates each
belonged to CC5, CC22 and CC9, respectively, as defined
by Freitas et al. [24]. Of the remaining 16 STs, nine were
included into six small CCs (CCs 27, 46, 94, 296, 639,
648), unlinked to the major ‘super-complex’; ST632
formed a ‘doubleton’ (i.e. was linked by a single-locus vari-
ant link to only one ST from the database) and six STs,
represented by single isolates, were singletons, i.e. were
not related to any ST in the database at the time of ana-
lysis. Thirty isolates (43.5%) in the investigated group
showed the MDR phenotype, which was significantly asso-
ciated (p = 0.00006) with isolates from the nosocomial
complex (Table 3 and Figure 3) but found also in CC5,
CC22 and CC94; this phenotype did not occur among
small CCs or singletons. Seventeen isolates, repre-
senting the nosocomial complex were additionally
studied by multilocus VNTR (variable number tan-
dem repeats) analysis (MLVA) to better elucidate the
relationships among these isolates. Altogether, nine
MLVA-types (MTs) were found (Table 3). Importantly,
the same MLVA-type, MT159 associated with ST78
was characteristic for isolates derived from samples

























































Figure 3 Distribution (%) of IS16, resistance phenotypes and virulenc
columns, isolates with STs typical for nosocomial E. faecium, grey columns,
groups are indicated by an asterisk. MDR, multi-drug resistance; AM-R, amp
gentamicin resistance; HLSR, high-level streptomycin resistance.IS16 was present in all 17 isolates included by MLST to
three lineages of nosocomial E. faecium and this marker
was limited to this group (Table 3 and Figure 3). The
espEfm gene occurred always together with intA among all
isolates of lineage 17 and in some isolates of lineage 78.
The fms19 pilin gene, detected in 29 isolates, was over-
represented among STs typical for nosocomial E. faecium
while other pilin genes, such as fms5, fms17 and fms21,
detected in 57, 49 and 46 isolates, respectively, occurred
among various CCs and singleton STs. Ampicillin resist-
ance, significantly associated with isolates of nosocomial
complex (10 of 17 isolates, 58.8%; p = 0.001), occurred also
in CC5 (6 isolates), CC22 and CC94 (1 isolate each). Se-
quencing of the 3′ part of the pbp5 gene revealed its 11
nucleotide alleles corresponding to 11 variants of the C-
terminal part of PBP5. Six alleles of the gene were new
(pbp5-24 to pbp5-29), two alleles (pbp5-20, pbp5-22)
were described previously among Polish hospital VREm
isolates [13] and three alleles were found in other stud-
ies: pbp5-30 occurred in a Portuguese animal strain of
E. faecium [25] and pbp5-31 and pbp5-32 in clinical iso-
lates TCGE70411_2 and 164306 also from Portugal (de-
posited as JN208888 and JN208885 in the GenBank,
respectively). For a single ampicillin-resistant isolate of
ST653 (lineage 78), pbp5 amplification was not achieved
despite repeated attempts. The majority (11 of 17 iso-
lates, 64.7%) of isolates belonging to three lineages of
nosocomial E. faecium showed resistance to ciprofloxa-
cin determined by mutations R61G and S80I/R in ParC
and S84I/R/Y in GyrA. Ciprofloxacin resistance was
also significantly over-represented among isolates of
















































e, resistance and plasmid genes among E. faecium isolates. Black
other E. faecium isolates. Significant differences (p < 0.05) between two
icillin resistance; CIP-R, ciprofloxacin resistance; HLGR, high-level
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CCs 5, 9 and 22. These isolates possessed mutations in
ParC mentioned above but had the wild-type QRDR in
GyrA. HLGR occurred in five isolates of lineages 18 and
78, and in single isolates of CC5 and CC22; this pheno-
type was determined by the presence of aac(6′)-Ie-aph
(2″) with an exception of an isolate from CC5 which
was negative for this gene. High-level resistance to
streptomycin (HLSR) was widely distributed among
studied isolates, and determined by the ant(6′)-Ia gene.
Tetracycline resistance was found also in various STs;
the major determinant of this phenotype was tet(M) (20
isolates), followed by tet(L) (17 isolates). These two
genes occurred together in 16 isolates. A single isolate
of ST633, belonging to CC22, harbored tet(S). The tet
(O) gene was absent in the studied group. For a single
tetracycline-resistant isolate of ST17 none of the four
tetracycline determinants studied was detected. Nine
isolates carried int of Tn916, and four the tndX gene of
Tn5397. These transposon-specific genes were not char-
acteristic for any lineage or complex (Table 3). Plasmid-
replication genes such as rep2pRE25, rep17pRUM and
rep18 pEF418 (26, 14 and 7 isolates, respectively), and
genes specifying toxin-antitoxin systems (TAS), axe-txe
and ω-ε-ζ (12 and 10 isolates, respectively) were signifi-
cantly associated with the group of isolates of nosocomial
E. faecium. Two other rep genes (rep1pIP501, reppLG1) were
widely distributed among all studied E. faecium isolates
and the reppMG1 gene occurred in two isolates (in a single
isolate of ST533 from CC22 and in a singleton ST647). All
ω-ε-ζ-positive isolates carried rep2pRE25, and nine isolates
showed a concomitant presence of axe-txe and rep17pRUM.
The relBE genes were found solely among five non-
nosocomial E. faecium (a difference in distribution with-
out statistical significance, p = 0.43), among various STs.
Discussion
In this study, Enterococcus spp. was used to evaluate the
impact posed by treated wastewater of two local WWTPs
on their receiver, the costal waters of Gulf of Gdansk.
Total counts of enterococci observed for raw (W-INF)
and treated (W-EFF, D-EFF) wastewater are consistent
with our previous study, showing similar, over 99% reduc-
tion capacity of applied treatment processes. It is also
reported in the literature that wastewater treatment pro-
cesses based on activated sludge, although they focus on
removal of nutrients and organic matter, simultaneously
reduce faecal indicators with high efficiency, reaching up
to 99.9% [18,22]. Due to the high number of enterococci
in raw wastewater, they are nevertheless released from a
WWTP in a number up to 6.1x105 CFU per 100 mL.
Thus, marine water sampled in the area directly impacted
by treated wastewater (W-MOut and D-MOut) showed a
higher number of enterococci than the one observed inVistula River mouth, however, lower by four orders of
magnitude in comparison to corresponding treated waste-
water (W-EFF and D-EFF). It should be noted that in mar-
ine outfalls (W-MOut, D-MOut) as well as in Vistula
River mouth enterococci were detected in number lower
than 100 CFU per 100 mL, i.e. the value set out by New
Bathing Water Directive 2006/7/EC for the costal water of
“excellent quality” [23].
It is suggested that enterococcal species composition in
faecal-impacted environment depends from the source of
contamination. In this study, two species most commonly
colonizing humans, E. faecalis and E. faecium comprised
together from 73% to 88% of enterococcal isolates in
tested wastewater samples (W-INF, W-BR, W-EFF and D-
EFF), 73% and 61% in marine outflows (W-MOut and D-
MOut, respectively) and 45% in the Vistula River mouth.
The predominant species in wastewater and marine water
impacted by treated wastewater was E. faecium (from 56
to 65%), which stayed at a similar level during treatment
processes, as determined also in our previous study [20].
Species distribution in wastewater samples is not well
understood, and affecting factors may include differences
in diet, climate, season and methods of detection. E. feaca-
lis was found to be the most prevalent species in wastewa-
ter samples in Sweden [26], E. faecium in Spain, UK,
Canada, France and Switzerland [26-29], while E. hirae
predominated in Portugal and United States [22,30]. Al-
though E. faecalis is typically the most abundant colonizer
of humans in the community (e.g. [26,31]), E. faecium is
generally most often associated with human microbial
contamination [27,29]. E. faecalis was reported from
agriculture-impacted waters [32] and E. hirae likely
originates mainly from cattle and pig faecal contamin-
ation [26], which explains high relative proportion of
these two species in Vistula River mouth. Apart from the
variability of contamination sources, proportion of par-
ticular species may differ due to the differences of ability
to sustain environmental stresses. In this study, enterococ-
cal composition might have been influenced by wastewa-
ter treatment processes and marine water characteristics.
The effect of wastewater treatment and marine environ-
ment was seen on phenotypes of antimicrobial resistance.
The positive selection of bacteria with resistance patterns
has been already suggested and noted in wastewater pro-
cesses [19,20,22]. In this study, the resistance rates to ampi-
cillin, ciprofloxacin, levofloxacin and erythromycin, noted
for E. faecium from raw wastewater (W-INF) were lower
than these observed for this species in the corresponding
treated wastewater (W-EFF), however, not statistically sig-
nificant (p > 0.05). Moreover, resistance rates to ampicillin,
ciprofloxacin, tetracycline and erythromycin observed in
marine outflow of WWTP Gdansk-Wschod (W-MOut)
were higher than in treated wastewater of this plant.
Such phenomenon was not observed for treated
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its marine outfall (D-MOut). Resistance rates among E.
faecium originating from D-MOut were, in general,
comparable to these detected in the Vistula River
mouth. It should be noted that treated wastewater from
WWTP Gdansk-Wschod has been discharged via mar-
ine outfall (W-MOut) for last 12 years while marine
outfall of WWTP Gdynia-Debogorze (D-MOut) has
been operating for last two years. The observed differ-
ences in resistance rate corresponding to the local im-
pact caused by long and short-term operated marine
outfalls (W-MOut and D-MOut) need further attention.
Significant rates of antimicrobial resistance, observed
for isolates of E. faecalis from wastewater and marine/
river waters, impacted by wastewater, are in agreement
with a recent study performed in six European countries,
showing that in Poland the rates of resistance for human
isolates of this species were usually among the highest,
both in the community and hospitals [33]. To our know-
ledge, no corresponding data are available for E. faecium
colonization in the community in Poland but a study
focused on hospital VRE isolates showed their ubiquitous
MDR phenotype and a high load of resistance genes [13].
In our study no vancomycin resistance were detected,
likely due to relatively low (below 10%) prevalence of VRE
in Polish hospitals [5], although such isolates are isolated
from the environment in other countries e.g., [34].
This study shows that hospital clones of E. faecium are
important carriers of resistance genes in wastewaters.
Most likely, in a significant part they originated from
hospital wastewater treated together with communal
wastewater. In our estimation, hospital wastewater con-
stitutes approximately 0.2% of both WWTPs’ daily in-
flow. The release of hospital-associated clones of E.
faecium to the environment was observed also by others
[24,28,35,36]. In our study, isolates belonging to the
major nosocomial HiRECC (formerly named CC17)
constituted altogether 24.6% of all isolates of E. faecium
subjected to typing, and were present at all sampling
sites. These isolates, apart from their inclusion into the
HiRECC by MLST, demonstrated several other pheno-
typic and genotypic features typical for nosocomial E.
faecium, i.e. they were resistant to ciprofloxacin and
ampicillin, in vast majority showed MDR phenotype,
and carried several resistance determinants, associated
both with mutations of chromosomal genes (gyrA, parC,
pbp5) and, in the case of aminoglycoside and tetracycline
resistance, with gene acquisition. Plasmids likely played an
important role in the later process, as some plasmid genes,
such as rep2pRE25, rep17pRUM and rep18 pEF418, and TAS
genes axe-txe and ω-ε-ζ were significantly more abundant
in isolates associated with HiRECC than among the
remaining isolates. As yet, the knowledge of distribution
of plasmid-associated genes in populations of E. faecium,especially in the context of their clonal composition,
remains limited. A study on 93 isolates of different
geographical origins and from various sites showed an
over-representation of rep17pRUM and reppMG1 among
nosocomial E. faecium, while, in contrast to our observa-
tions, rep18 pEF418 was not detected [37]. Moreover, we
did not observe reppMG1 among HiRECC of E. faecium.
These differences may be due to a high prevalence of VRE
(58 isolates) among 93 isolates studied by Rosvoll et al.
what may explain differences in the plasmid content. The
same study also reported the co-localization of ω-ε-ζ with
rep2pRE25 and axe-txe with rep17pRUM on the same plas-
mids, in concordance with our findings, showing a fre-
quent joint occurrence of these pairs of genes. Another
study, performed on 99 invasive isolates from Norway,
mostly of HLGR phenotype, showed a significantly higher
prevalence of rep2pRE25 and rep17pRUM among the major
nosocomial HiRECC [38]. This study as well some others
[24,39] also demonstrated a common presence of reppLG1
among E. faecium from hospital settings and in animals.
Our findings indicate that this type of replicon is even
more ubiquitous in E. faecium than previously reported.
All rep genes mentioned above are typically associated
with plasmids carrying various antimicrobial resistance
genes [39,40], GenBank accession number AF408195. In
addition to genes determining antimicrobial resistance
and genes associated with MGE, isolates of nosocomial
HiRECC analyzed in our study carried such molecular
markers as IS16 and the esp gene together with the intA
gene characteristic for ICEEfm [41,42]. Another patho-
genicity factor, the fms19 gene of the pilin gene cluster
4 (PGC4) showed increased prevalence among these
isolates. Similar observation was made for a representa-
tive collection of 433 E. faecium isolates from various
sources [43].
In a study that followed enterococci in a continuum
from hospital and retirement home wastewaters through
a WWTP to a river, a gradual decrease in the proportion
of E. faecium isolates representing hospital-associated
STs was observed, likely due to the “dilution” of HiRECC
representatives by more diverse and less drug-resistant
strains originating from the community [28]. Because in
our study only selected representatives of obtained iso-
lates were investigated, it is not possible to determine
precise tendencies in their frequency from the WWTP
influent to effluent and water, however, resistant entero-
cocci, both HiRECC and non-HiRECC, are clearly able
to survive the treatment process, what results in their re-
lease into marine and river waters. Moreover, using an
additional typing method, MLVA, we were able to find
isolates with the same characteristics in the effluent of
WWTP and its marine outfall, suggesting ability of such
clones to survive in the environment for at least some
time. It seems plausible that hospital resistant clones
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survival not only in the hospital settings but also in the
environment. Such features would include resistance to
disinfectants and ultraviolet light, additional metabolic
pathways and ability to form biofilms. Moreover, determi-
nants of some of the mentioned adaptation factors are
found co-resident in plasmids harboring resistance genes,
suggesting co-selection. For example, pLG1-type plasmids
of E. faecium carry not only resistance determinants
against aminoglycosides, glycopeptides and macrolides
but also pili genes and carbon uptake-utilization genes
[38,39]. Pheromone-responsive plasmids of E. faecalis
apart from resistance to aminoglycosides, glycopeptides,
penicillins and macrolides may encode bacteriocins, add-
itional pili and UV-resistance determinants [40]. Thus,
nosocomial HiRECCs, released by WWTPs, are equipped
in whole sets of genes with various adaptive benefits and
often located within MGE. It was also demonstrated that
MGEs can be transferred in a WWTP [44], further under-
ling the importance of threat posed by such organisms.
There is a selection pressure for survival of resistant
strains and their tranconjugants due to release of antibi-
otics to the environment, especially in the hospital efflu-
ents [45], and even sub-inhibitory concentrations may be
effective in selection for resistance [46].
Conclusions
This study describes the species composition, resistance
profiles and clonal relationships of enterococci isolated
from WWTPs located in Gdansk, their marine outfalls
to the Gulf of Gdansk and from Vistula River. It was ob-
served that these WWTPs release enterococcal strains
resistant to various antimicrobial compounds to the re-
cipient water environment. Molecular analyses revealed
the presence of clones associated with nosocomial HiR-
ECCs, and, in the case of E. faecium isolates of lineages
17, 18 and 78 of former CC17 abundant in resistance de-
terminants, MGE genes and pathogenicity factors. The
presence of HiRECCs in wastewaters and marine/river
environment highlights the need for further detailed
analyses to better understand the survival and spread of
drug-resistant strains in water ecosystems, and to eluci-
date the ways to curb such dissemination.
Methods
Acquisition of samples and isolation of enterococci
Once a month in April, June, August and October in 2011
of the flow proportioned composited samples of wastewa-
ter were taken from two local WWTPs: Gdansk-Wschod
from influent (W-INF), effluent (W-EFF), and wastewa-
ter from activated sludge bioreactor (W-BR) and from
Gdynia-Debogorze effluent (D-EFF). The two WWTPs
treat sewage from approximately 920 000 inhabitants
(for details see Figure 1). In the same period of time andwith the same frequency marine outfalls of those WWTPs
(W-MOut and D-MOut, respectively) as well as Vistula
River mouth were also sampled for isolation of entero-
cocci. Marine samples were taken at the depth of approxi-
mately one meter below the surface once a month in
April, June, August and October of 2011. Location of
sampling points and their characteristics are provided in
Figure 1. Enterococci were detected using the membrane
filtration method. To this end, appropriate dilutions of
analyzed samples were filtered in duplicate through
0.45 μm cellulose-acetate filters (EMD Millipore Cor-
poration, Billerica, MA, USA), which were then placed
on Enterococcus selective agar (Merck, Darmstadt,
Germany) and incubated at 37°C for 48 h (ISO 7899–
2:2000). Dark red or maroon colonies were considered
presumptive enterococci. For further investigations,
representative isolates were taken from membranes pre-
senting from 20 to 50 typical colonies and stored in nu-
trient broth supplemented with 15% glycerol at −80°C.
Species identification, DNA isolation, susceptibility testing
and statistical analysis
The species identification and drug susceptibility of pre-
sumptive enterococci were determined by the Phoenix™
Automated Microbiology System (BD, New Jersey, USA)
according to the manufacturer’s instructions. Since it is
not possible to distinguish E. casseliflavus and E. galli-
narum using this system, the classification: E. casselifla-
vus/gallinarum was used. The susceptibility tests, based
on microdilution, were carried out for 11 antimicrobial
agents: gentamicin (GM), streptomycin (ST), ampicillin
(AM), daptomycin (DAP), vancomycin (VA), teicoplanin
(TEC), linezolid (LZD), fluoroquinolones (ciprofloxacin -
CIP, levofloxacin - LVX), tetracycline (TE), erythromycin
(E) and quinupristin-dalfopristin (SYN) (E. faecium only).
Obtained minimal inhibitory concentrations (MIC) were
evaluated according to the guidelines of Clinical and La-
boratory Standards Institute [47]. Isolates were defined as
multidrug-resistant (MDR) when they showed resistance
to three or more compounds tested [48]. Bacterial DNA
was purified using the Genomic DNA Prep Plus kit
following the manufacturer’s instructions (A&A Biotech-
nology, Gdynia, Poland). Differences in distributions were
evaluated using the χ2 test, with the p values < 0.05 con-
sidered significant.
MLST and MLVA of E. faecium
MLST for E. faecium was performed by sequencing of
seven house-keeping genes as described by Homan et al.
[49]. The allele numbers and STs were assigned with the
use of Internet database http://efaecium.mlst.net/ (5th July
2013, date last accessed). Novel alleles and allelic profiles
were submitted to the database. MLST data were analyzed
with Sequence Type Analysis and Recombinational Tests
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used to elucidate the relationships of STs with known
CCs, using the comparative eBURST option available at
http://eburst.mlst.net/v3/enter_data/comparative/ (5th July
2013, date last accessed). Further inclusion of E. faecium
STs into specific CCs and lineages was performed fol-
lowing other studies [9,24]. MLVA was performed as de-
scribed by others [52].
Detection and analysis of genes associated with virulence,
antimicrobial resistance and MGE in E. faecium
The full list of primers used for gene detection and se-
quencing is provided in Additional file 1: Table S1. PCR-
based detection of IS16, virulence-associated genes (fms21,
fms17, fms5 and fms19, representing each of four pilin
gene clusters in E. faecium, and the espEfm gene), genes de-
termining resistance to tetracycline {tet(M), tet(O), tet(L),
tet(S)}, HLGR (aac(6′)-Ie-aph(2″), HLSR (ant(6′)-Ia) and
genes specific for MGE, such as intA of ICEEfm1, int of
Tn916 transposon, tndX of Tn5397 transposon, entero-
coccal plasmid replication genes rep1pIP501, rep2pRE25,
rep17pRUM, rep18pEF418, reppMG1, reppLG1 and TAS genes
axe-txe, ω-ε-ζ, relBE was performed as described in other
studies [13,41,53-59], following the conditions described
herein. Previously characterized clinical isolates of Strepto-
coccus agalactiae, E. faecium and E. faecalis harbouring
pilin genes, IS16, espEfm, intA of ICEEfm1, int of Tn916,
tndX of Tn5397, tet(M), tet(O), tet(L), tet(S), aac(6′)-Ie-
aph(2″), ant(6′)-Ia, rep1pIP501, rep2pRE25, ω-ε-ζ [13,60,61]
served as positive controls. In cases when positive controls
were not available (rep18pEF418, reppMG1, reppLG1, axe-txe,
relBE), a few randomly selected PCR products were
verified by sequencing and served further as controls.
Ampicillin-resistance determinant, the pbp5 gene was ana-
lysed by sequencing of the part encoding C-terminal
transpeptidase domain in PBP5 [62]. New sequence vari-
ants, pbp5-24 to pbp5-29 alleles were submitted to the
GenBank (acc. numbers KC594860-KC594865, respect-
ively). The quinolone-determining regions (QRDR) in the
gyrA and parC genes were sequenced and analysed as
described by others [63].
Additional file
Additional file 1: Table S1. Primers used in the study for PCR and
sequencing.
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